CASI Pharma (CASI) Reports Q2 Loss of $0.52

CASI Pharma (NASDAQ: CASI) reported Q2 EPS of ($0.52). Revenue for the quarter came in at $3.98 million.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
• Goldman Sachs hosts investor trip to Athens with Greek banks
• Sunbelt Rentals Holdings, Inc. (SUNB) Reports Q2 EPS of $1.18